CATEGORIES

© Copyright 2004; Hanoitimes - Economic and Urban Newspaper;

The tribune of Hanoi People’s Committee

Publication Permit: 29/GP-CBC

Editor - in - Chief: Nguyen Thanh Loi

Managing Editor: Ta Thu Giang

Email : thugiang@hanoitimes.vn

Head Office: 21 Huynh Thuc Khang Street, Dong Da District, Hanoi

Branch Office: 221 Tran Phu Street, Ha Dong District, Hanoi

WORDS ON THE STREET 70th anniversary of Hanoi's Liberation Day Vietnam - Asia 2023 Smart City Summit Hanoi celebrates 15 years of administrative boundary adjustment 12th Vietnam-France decentrialized cooperation conference 31st Sea Games - Vietnam 2021 Covid-19 Pandemic
Home / Investment / News
Japan’s Taisho Group to raise stake Vietnam’s DHG Pharmaceutical to 35%
Hai Yen 10:30, 2019/02/18
At the current market price of VND93,000 (US$4.03) apiece, Taisho may spend about VND86 billion ($3.7 million) to buy the share amount in subject.
Japan-based Taisho Pharmaceutical has registered to purchase an additional of nearly 1 million shares in Vietnam’s DHG Pharmaceutical, lifting its holding in the latter to nearly 35%, according to a disclosure by the Ho Chi Minh Stock Exchange (HoSE). 
 
Illustrative photo.
Illustrative photo.
The transaction period is stated from February 20 to March 21, 2019 via put-through or order-matching.

At the current market price of VND93,000 (US$4.03) apiece, Taisho may spend about VND86 billion ($3.7 million) to buy the share amount in subject.

Taisho is currently a major shareholder of DHG with over 44,83 million shares, equivalent to 34.29% of the company’s charter capital. After the transaction, the number of shares will increase to over 45.76 million, equivalent to 34.99% of the charter capital. 

DHG’s largest shareholder is State Capital Investment Corporation (SCIC) with 56.6 million shares or 43.31% of the medicine maker’s charter capital. 

As of present, DHG Pharmaceutical has removed its foreign ownership limit, presenting opportunities for foreign investors to up their stakes in the company. 

Taisho Pharmaceuticals, headquartered in Tokyo, is a leading Japanese pharmaceutical company specializing in the manufacturing of pharmaceutical products and non-prescription dietary supplements under well-known brands.
Comments
Other news
18:03, 2025/02/22
Vietnam attracts South Korean tech investment at SEMICON Korea 2025
The event provided a platform for Vietnam to showcase its semiconductor potential and reaffirm its commitment to developing high-tech industries and strengthening international cooperation.
16:46, 2025/02/20
Swedish group plans US$1 billion investment in Binh Dinh recycling plant
By creating a large number of jobs and promoting a green economy, the initiative is important in establishing Vietnam as a global hub for the circular textile sector.
10:52, 2025/02/13
Samsung plans to invest in AI, semiconductors in Vietnam
Vietnam will continue improving its investment environment and driving strategic breakthroughs in order to usher in a new era of economic development.
17:20, 2025/02/07
Vietnam's data center construction costs among the lowest in Asia Pacific
The country has a lot of potential to become one of the most important data markets in the region.
21:05, 2025/02/03
Bright prospects for FDI inflows into Vietnam in 2025
Market size, growth potential, low labor costs, and stable political and social conditions continue to be Vietnam’s selling points in attracting foreign investors.
10:57, 2025/01/30
Foreign companies confirm investment expansion in Vietnam in 2025
Some foreign firms are optimistic about Vietnam's economic prospects in 2025 and plan to expand investment, focusing on sustainability across sectors.